Luma Group — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Curve BiosciencesMay 2024
Platform using blood-based biomarkers and AI to detect and monitor chronic diseases like cirrhosis through organ-specific signals
Mountain View, US
CHUBA OYOLU(Executive Officer)NATHAN HUNKAPILLER(Executive Officer)SHAN XIANG WANG(Executive Officer, Director)RITISH PATNAIK(Executive Officer, Director)
BoardTHEMASAP KHAN(Director)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.